Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 01/14/09 → 10/7/11 |
Funding
- Gilead Sciences Incorporated: $12,052.00
A Phase IB Study of the SAFETY AND Pharmacokinetics of Ritonavir-Boosted Elvitegravir (GS-9137/r) Plus a Background Regimen (BR) in HIV-1 Infected, Antiretroviral Treatment-Experienced Adolescents
- Nachman, Sharon (PI)
Project: Research